Autoimmune Diseases Market in the US 2015-2019


#296951

95pages

Technavio

$ 2500

In Stock

About Autoimmune Diseases
Autoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation, pain, and organ damage. It is also known as a disease of flare-ups and remissions, and can range from mild to life-threatening in severity. No cure exists for autoimmune diseases yet. Autoimmune diseases can affect the cardiovascular system, brain, nerves, musculoskeletal system, skin, lungs, kidneys, glands, or joints. They are caused by genetic, infectious, and environmental factors. According to NIH, there are more than 80 clinically different autoimmune diseases. Some of the common types of autoimmune diseases are ankylosing spondylitis, Crohn's disease, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and psoriasis.

Technavio's analysts forecast the autoimmune diseases market in the US to grow at a CAGR of 6.17% over the period 2014-2019.

Covered in this Report
The report includes the present scenario and the growth prospects of the autoimmune diseases market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of autoimmune diseases.

Technavio's report, Autoimmune Diseases Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast for individual diseases as well as the overall market and pipeline landscape. The report includes a discussion of the key vendors operating in this market.

Key Vendors
AbbVie
Amgen
Biogen
F. Hoffmann-La Roche
Janssen Pharmaceuticals

Other Prominent Vendors
AB Science
Acorda Therapeutics
aTyr Pharma
Baxter
Celgene
Celltrion
Coherus BioSciences
Daiichi Sankyo
Eli Lilly
GlaxoSmithKline
HGS
Hospira
Idera
Immunomedics
ImmuPharma
Invion
Latona Life Sciences
MedImmune
Merck
Novartis
Opexa Therapeutics
Principia
Reata Pharmaceuticals
Regeneron
Sanofi
Sobi
Takeda
Teva
UCB
Vaccinex
Vitae Pharmaceuticals

Key Market Driver
Unmet Medical Needs
For a full, detailed list, view our report

Key Market Challenge
High Cost of Therapy
For a full, detailed list, view our report

Key Market Trend
Increase in Public Awareness
For a full, detailed list, view our report

Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?